Lola Lecru

Lola Lecru is an experienced professional in the field of biomarker strategy, translational research, and fibrosis. With a background in physiology and pathology, Lola has held key roles at Domain Therapeutics and Galapagos, leading the scientific strategy for biomarker development and validation. Lola's expertise includes identifying and validating biomarkers in various therapeutic areas such as lung, liver, kidney, skin, and NASH. With a strong research background in renal fibrosis and nephropathy, Lola has contributed significantly to the understanding of disease pathways and therapeutic targets. Lola's educational background includes a PhD in Physiology, Pathology, and Related Sciences.